Kenvue stock edges higher as quarterly earnings beat expectations
Published on 09/20/2026 at 13:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Kenvue Inc. stock (ISIN US49177J1025) is trading around USD 14.57 as of September 19, 2026, after the consumer health group delivered a modest earnings beat in its most recent quarter with earnings per share slightly above analyst expectations.
Quarterly figures show earnings beat
According to TradingView, Kenvue reported quarterly earnings per share of USD 0.29 in its latest reported quarter, compared with a consensus estimate of USD 0.28 per share, representing an upside of around 3.6 percent against the forecast on that metric in the period that ended within the last nine months.
In the same quarter, Kenvue generated revenue of USD 3.84 billion versus an estimated USD 3.85 billion, meaning reported sales came in USD 0.01 billion below the revenue expectation while still reflecting a high single-digit billion scale for the business in this recent reporting period, as detailed by TradingView.
Profitability and net income trends
The same dataset from TradingView also shows that Kenvue posted net income of USD 420.00 million in the latest quarter, compared with USD 322.00 million in the preceding quarter, implying that quarterly net profit increased by USD 98.00 million, or 30.43 percent, on a sequential basis.
For dividend-focused investors, TradingView indicates that the company currently pays a quarterly dividend of USD 0.21 per share, corresponding to a trailing twelve month dividend yield of 5.45 percent at recent price levels, which is a relatively high cash return profile compared with many large consumer defensive peers.
Valuation metrics and sector positioning
Sector comparisons compiled by Stock Titan list Kenvue among top consumer defensive stocks by return on assets, with an ROA of 5.43 percent and a market capitalization of USD 34.21 billion based on recent figures.
That return-on-assets level means Kenvue is converting its asset base into profit at a mid-single-digit rate, a profile that is broadly in line with established consumer product groups and supports the sustainability of the current dividend payout ratio indicated in portal data for the latest fiscal period.
Stock price level and trading range
Recent price data from a major finance portal show Kenvue stock quoted at USD 14.57 on the New York Stock Exchange as of September 19, 2026, with the shares having moved up 0.53 percent over the prior 24 hours and having declined 36.26 percent over the last year, while the weekly change over the last seven days is negative 0.59 percent and the monthly performance is down 8.16 percent.
According to the same portal, Kenvue stock currently trades within a 52-week range of USD 17.67 to USD 24.10, so the latest price around USD 14.57 stands clearly below the 52-week low threshold, underlining that the shares are in a depressed zone relative to their trading history over the past year.
Kenvue stock key data
- Company: Kenvue Inc.
- ISIN: US49177J1025
- Ticker: KVUE
- Trading venue: NYSE
- Price (as of September 19, 2026): 14.57 USD
- Market capitalization: 34.21 billion USD (as of September 19, 2026)
- Sector / Industry: Consumer Defensive / Consumer Health
- Index membership: S&P 500
